Every day I wake up, someone text me like, hey, Pinelon did this to me
Know why a new medicine or treatment is prescribed and how it will help you
Efficacy Type 2 Diabetes SURPASS-2 Trial A direct comparison between tirzepatide and semaglutide in the SURPASS-2 trial demonstrated: HbA1c reduction : Tirzepatide (15 mg): up to 2.3% Semaglutide (1 mg): 1.9% Average weight loss : Tirzepatide: 5.5 kg Semaglutide: 3.8 kg Meta-Analysis Findings A meta-analysis of multiple trials confirmed tirzepatides superiority: 5 mg dose : 1.5 higher odds of achieving 5% weight loss than semaglutide 10 mg dose : 3.0 higher odds 15 mg dose : 4.2 higher odds However, higher tirzepatide doses also led to slightly higher discontinuation rates due to gastrointestinal side effects
Multi-omic analyses of DKO* skin and human psoriatic lesions identify two opposing molecular changes: upregulation of FABP5 and downregulation of the key ferroptosis suppressive protein glutathione peroxidase 4 (GPX4)
The letter addresses such challenges as potential limitations of pooled data, single arm trials, and post hoc analyses, among others
Doses of 250500 mg per day are safe for healthy adults for up to 6 months